JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.83B |
| 2 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.45B |
| 3 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.34B |
| 4 |
EA
Electronic Arts
EA
|
+$903M |
| 5 |
Automatic Data Processing
ADP
|
+$825M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.63B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.06B |
| 3 |
Meta Platforms (Facebook)
META
|
+$942M |
| 4 |
Nike
NKE
|
+$779M |
| 5 |
Union Pacific
UNP
|
+$543M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 25.23% |
| 2 | Financials | 13.17% |
| 3 | Technology | 12.62% |
| 4 | Healthcare | 10.37% |
| 5 | Consumer Discretionary | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Boston Scientific
BSX
$61.5B
| $1.81B | 0.35% |
47,058,256
+2,701,658
| +6% | +$94.4M |
2013 Q2
21 quarters
|
|
52
Medtronic
MDT
$114B
| $1.81B | 0.35% |
18,400,648
-659,878
| -3% | -$61M |
2013 Q2
21 quarters
|
|
53
ExxonMobil
XOM
$698B
| $1.79B | 0.34% |
21,059,203
-17,456
| -0.1% | -$1.43M |
2013 Q2
21 quarters
|
|
|
54
Union Pacific
UNP
$165B
| $1.78B | 0.34% |
10,959,404
-3,609,890
| -25% | -$543M |
2013 Q2
21 quarters
|
|
55
Norfolk Southern
NSC
$71.2B
| $1.74B | 0.33% |
9,612,243
-2,367,105
| -20% | -$404M |
2013 Q2
21 quarters
|
|
56
General Dynamics
GD
$89.3B
| $1.73B | 0.33% |
8,451,126
+1,465,938
| +21% | +$287M |
2013 Q2
21 quarters
|
|
57
EOG Resources
EOG
$78.5B
| $1.71B | 0.33% |
13,396,781
-1,890,828
| -12% | -$230M |
2013 Q2
21 quarters
|
|
58
Comcast
CMCSA
$74.2B
| $1.7B | 0.33% |
47,961,947
+8,087,141
| +20% | +$286M |
2013 Q2
21 quarters
|
|
59
Xcel Energy
XEL
$45.7B
| $1.63B | 0.31% |
34,544,260
-3,899,813
| -10% | -$184M |
2013 Q2
21 quarters
|
|
|
EA
60
DELISTED
Electronic Arts
EA
| $1.59B | 0.3% |
13,197,629
+7,005,782
| +113% | +$903M |
2013 Q2
21 quarters
|
|
61
AutoZone
AZO
$47B
| $1.58B | 0.3% |
2,034,551
+84,961
| +4% | +$62.5M |
2013 Q2
21 quarters
|
|
62
Vanguard Total International Bond ETF
BNDX
$82.5B
| $1.56B | 0.3% |
28,628,840
+3,985,142
| +16% | +$218M |
2015 Q1
14 quarters
|
|
63
Berkshire Hathaway Class B
BRK.B
$1.1T
| $1.56B | 0.3% |
7,280,455
+468,461
| +7% | +$96.1M |
2013 Q2
21 quarters
|
|
64
Zimmer Biomet
ZBH
$17.2B
| $1.52B | 0.29% |
11,943,307
+1,064,728
| +10% | +$127M |
2013 Q2
21 quarters
|
|
65
Charter Communications
CHTR
$12.2B
| $1.5B | 0.29% |
4,587,759
-1,079,199
| -19% | -$329M |
2013 Q2
21 quarters
|
|
66
ConocoPhillips
COP
$163B
| $1.49B | 0.29% |
19,234,910
+118,325
| +0.6% | +$8.53M |
2013 Q2
21 quarters
|
|
67
Cigna
CI
$75.1B
| $1.45B | 0.28% |
6,984,470
+759,149
| +12% | +$141M |
2013 Q2
21 quarters
|
|
|
68
JPMorgan BetaBuilders Canada ETF
BBCA
$11B
| $1.45B | 0.28% |
+29,437,708
| New | +$1.45B |
2018 Q3
0 quarters
|
|
69
Accenture
ACN
$127B
| $1.43B | 0.27% |
8,378,283
-1,375,598
| -14% | -$229M |
2013 Q2
21 quarters
|
|
|
PXD
70
DELISTED
Pioneer Natural Resource Co.
PXD
| $1.42B | 0.27% |
8,170,083
-1,342,843
| -14% | -$240M |
2013 Q2
21 quarters
|
|
71
CVS Health
CVS
$112B
| $1.39B | 0.27% |
17,699,785
-209,667
| -1% | -$15M |
2013 Q2
21 quarters
|
|
72
HDFC Bank
HDB
$114B
| $1.39B | 0.27% |
59,021,312
+3,268,284
| +6% | +$83.3M |
2013 Q2
21 quarters
|
|
73
Ross Stores
ROST
$70.6B
| $1.38B | 0.26% |
13,907,770
+3,599,781
| +35% | +$331M |
2013 Q2
21 quarters
|
|
74
Marathon Petroleum
MPC
$130B
| $1.37B | 0.26% |
17,162,787
+1,409,372
| +9% | +$111M |
2013 Q2
21 quarters
|
|
75
Vertex Pharmaceuticals
VRTX
$129B
| $1.37B | 0.26% |
7,117,216
+355,139
| +5% | +$63.2M |
2013 Q2
21 quarters
|
|
Similar funds
JP Morgan Chase's Q3 2018 Portfolio in Review
As of Q3 2018, JP Morgan Chase held 6,019 positions worth $522B, up 7.4% from $486B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q3 2018 filing shows 448 new, 2,597 increased, 2,100 reduced and 312 closed positions. Its largest new stake was JPMorgan BetaBuilders Canada ETF: 29,437,708 shares worth $1.45B. The largest sale was Broadcom, an estimated $1.63B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q3 2018 buy was JPMorgan BetaBuilders Canada ETF: 29,437,708 shares worth $1.45B.
- JP Morgan Chase added most to JPMorgan BetaBuilders Japan ETF in Q3 2018, an estimated $1.83B increase.
- JP Morgan Chase's biggest Q3 2018 reduction was Broadcom, cutting an estimated $1.63B.
- JP Morgan Chase fully exited Cavium, Inc. in Q3 2018, selling an estimated $316M.
- JP Morgan Chase's ten largest holdings make up 18% of its $522B portfolio in Q3 2018.
- JP Morgan Chase opened 448 new positions and closed 312 in Q3 2018.
- JP Morgan Chase's portfolio value rose 7.4% quarter-over-quarter to $522B.
Based on JP Morgan Chase's 13F filing for Q3 2018, filed 7 Nov 2018.